Immune Thrombocytopenia - A Neglected Adverse Event of PD-1 and PD-L1 Inhibitors in Clinical Trials - In Reply

Yucai Wang, Fang Yang, Michael L. Wang

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1640-1641
Number of pages2
JournalJAMA Oncology
Volume5
Issue number11
DOIs
StatePublished - Nov 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this